- Published on 09 May 2014
New research into understanding how the brain adapts and improves its hearing abilities through the use of hearing technologies could play an important role in the future management of dementia. The use of devices such as hearing aids and cochlear implants to delay and/or reverse cognitive decline in conditions such as dementia was one of the topics discussed at the XXXII World Congress of Audiology in Brisbane this week.
Professor Stephen Crain (picture), from the Macquarie University describes central auditory plasticity as the adaptability of the brain’s cerebral cortex to process sound more effectively in response to new stimuli:“We now know the brain has a remarkable ability to regrow and adapt itself to process new kinds of information and relearn tasks, especially in early childhood, but across the lifespan.” The peak of brain’s central auditory plasticity occurs in children between the ages of two and four. It’s before this critical time that infants with hearing loss benefit most from being fitted with a hearing device so that the regions of the brain that processes sound information and language can develop most optimally.
“Although the brain has its greatest plasticity in very young children, it continues to have remarkable adaptive abilities at all ages." Preliminary research supports the notion that adults with hearing aids develop new neural pathways in the brain to more fully utilise the information created by these devices. To some extent this conclusion is supported by anecdotal evidence that many adults who are initially unhappy with their hearing devices suddenly report dramatic improvement a month or so later.“We don’t know yet exactly what is happening in the brains of these adults, but their observations suggest that perceptual processing changes are taking place in the brain as it adjusts to the information provided by hearing devices,” Professor Crain explained.
“It’s early days but as the degree of hearing loss is highly correlated with the risk of dementia it seems highly likely that intervention with a hearing device to restore hearing in adulthood could assist in delaying the onset of dementia.”Source: International Society of Audiology
Sonova announces the appointment of Victoria E. Carr-Brendel as Group Vice President (GVP) Cochlear Implants of Sonova and President of Advanced Bionics and of Ludger Althoff as GVP Operations.
Pharmafile, a leading portal for pharmaceutical industry news, events, and service company listings, recently ran an article on hearing loss as the next frontier for pharmaceutical success.
Watch here our conversation with Rayovac MicroPower executives Glen Rutherford, General Manager, and Paula Brinson-Pyke, International Marketing Director.
At the Rayovac Evening of Excellence held on the Wednesday evening of EUHA, the 2018 European Audiologist of the Year was announced.
State-of-the-art hearing aids from three global manufacturers have won their producers the prestigious right to show off their products at next year's Consumer Electronics Show as CES Innovation Awards Honorees.
The 8,000 attendees from 83 countries were spoilt for choice at the 2018 EUHA Congress. In the auditorium were 30 lectures, workshops and roundtables to participate in.
Researchers from the University of California, San Francisco recently found that the lack of a specific gene may be related to loss of inner and outer hair cells, and that an experimental drug can prevent this inner ear damage, thus protecting hearing.
Phonak introduces Marvel - a revolutionary hearing aid family that combines the benefits of exceptional speech understanding and reduced listening effort in noise with the ability to stream all audio content seamlessly from iPhone, Android smartphone [ ... ]